Target intelligence / Profile preview

Osmotic gradient in tissue

Molecular classification
Other (physicochemical property; not a protein, receptor, or molecular entity)
01

Overview

The osmotic gradient in tissue refers to the difference in solute concentration across a semipermeable barrier, usually a cell membrane or tissue interface. This gradient determines the *direction and extent of water movement* via osmosis, where water flows from areas of low solute concentration (higher water potential) to areas of high solute concentration (lower water potential). In biological systems, osmotic gradients underlie critical processes such as cellular hydration, tissue fluid balance, and the dynamic regulation of cell volume. Disruption or rapid shifts in these gradients contribute to tissue injury, edema, and can complicate therapy (such as rapid sodium correction or dehydration). This is a physicochemical property relevant to tissue physiology, rather than a distinct molecular entity.

Other names
Osmotic gradientOsmotic pressure gradientOsmotic balanceOsmotic differenceOsmotic potential difference
02

Mechanism of action

None directly (but drugs like mannitol or hypertonic saline increase extracellular osmolarity to draw water out of tissues via osmotic gradients)

03

Biological functions

Regulation of water movement across membranesMaintenance of tissue hydrationCellular volume regulationOsmoregulation in tissuesFacilitation of solute transport (passive)
04

Disease associations

Other (not disease-specific, but abnormal osmotic gradients contribute to edema, dehydration, tissue injury, and can have roles in kidney disease, neurological injury (e.g., cerebral edema), and fluid balance disorders)
05

Safety considerations

Rapid changes in osmotic gradients can cause cellular swelling (cytolysis) or shrinking (plasmolysis), particularly in the brain ("osmotic demyelination syndrome" with rapid correction of hyponatremia), and pulmonary edema or dehydration in other tissues
06

Interacting drugs

None directly (but drugs/electrolytes which affect tissue osmolarity or water movement, such as mannitol, hypertonic saline, and diuretics, may indirectly manipulate osmotic gradients)
07

Biomarkers

None specific (tissue or plasma osmolality/osmolarity measurements used in clinics; not a molecule or clinical biomarker as such)

Beyond the preview

Go deeper on Osmotic gradient in tissue.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Osmotic gradient in tissue.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call